Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination antifungal therapy.
Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH. Johnson MD, et al. Antimicrob Agents Chemother. 2004 Mar;48(3):693-715. doi: 10.1128/AAC.48.3.693-715.2004. Antimicrob Agents Chemother. 2004. PMID: 14982754 Free PMC article. Review. No abstract available.
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.
Odds FC, Motyl M, Andrade R, Bille J, Cantón E, Cuenca-Estrella M, Davidson A, Durussel C, Ellis D, Foraker E, Fothergill AW, Ghannoum MA, Giacobbe RA, Gobernado M, Handke R, Laverdière M, Lee-Yang W, Merz WG, Ostrosky-Zeichner L, Pemán J, Perea S, Perfect JR, Pfaller MA, Proia L, Rex JH, Rinaldi MG, Rodriguez-Tudela JL, Schell WA, Shields C, Sutton DA, Verweij PE, Warnock DW. Odds FC, et al. J Clin Microbiol. 2004 Aug;42(8):3475-82. doi: 10.1128/JCM.42.8.3475-3482.2004. J Clin Microbiol. 2004. PMID: 15297486 Free PMC article.
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavathu E, Ostrosky-Zeichner L, Pfaller M, Rinaldi M, Schell W, Walsh T. Espinel-Ingroff A, et al. J Clin Microbiol. 2005 Oct;43(10):5243-6. doi: 10.1128/JCM.43.10.5243-5246.2005. J Clin Microbiol. 2005. PMID: 16207990 Free PMC article.
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.
Ostrosky-Zeichner L, Kontoyiannis D, Raffalli J, Mullane KM, Vazquez J, Anaissie EJ, Lipton J, Jacobs P, van Rensburg JH, Rex JH, Lau W, Facklam D, Buell DN. Ostrosky-Zeichner L, et al. Eur J Clin Microbiol Infect Dis. 2005 Oct;24(10):654-61. doi: 10.1007/s10096-005-0024-8. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16261306 Clinical Trial.
Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.
Chaturvedi V, Ramani R, Ghannoum MA, Killian SB, Holliday N, Knapp C, Ostrosky-Zeichner L, Messer SA, Pfaller MA, Iqbal NJ, Arthington-Skaggs BA, Vazquez JA, Sein T, Rex JH, Walsh TJ. Chaturvedi V, et al. Antimicrob Agents Chemother. 2008 Apr;52(4):1500-2. doi: 10.1128/AAC.00574-07. Epub 2008 Jan 28. Antimicrob Agents Chemother. 2008. PMID: 18227180 Free PMC article.
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.
Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, Rex JH, Alexander BD, Andes D, Brown SD, Chaturvedi V, Ghannoum MA, Knapp CC, Sheehan DJ, Walsh TJ. Pfaller MA, et al. J Clin Microbiol. 2008 Aug;46(8):2620-9. doi: 10.1128/JCM.00566-08. Epub 2008 Jun 25. J Clin Microbiol. 2008. PMID: 18579718 Free PMC article.
207 results